Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
1.935
-0.385 (-16.59%)
Mar 18, 2026, 1:35 PM EDT - Market open

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-27.11-29.92-39.26-28.26-8.52-3.78
Depreciation & Amortization
-----0
Stock-Based Compensation
2.221.633.410.180.150.34
Other Adjustments
-0.13-0.720.240.19-1.592.05
Changes in Accounts Payable
-0.092.290.333.01-0.50.78
Changes in Accrued Expenses
-2.03-5.146.884.611.51-0.77
Changes in Other Operating Activities
0.6-1.690.071.31-1.71-2.33
Operating Cash Flow
-26.55-33.54-28.32-18.96-10.67-4.07
Short-Term Debt Issued
0.840.980.67---
Short-Term Debt Repaid
-0.66-0.52-0.67---
Net Short-Term Debt Issued (Repaid)
0.190.46----
Long-Term Debt Issued
-----3.11
Net Long-Term Debt Issued (Repaid)
-----3.11
Issuance of Common Stock
25.8523.1933.177.7931.69.38
Net Common Stock Issued (Repurchased)
25.8523.1933.177.7931.69.38
Financing Cash Flow
30.7323.6533.177.7931.612.83
Net Cash Flow
4.19-9.894.85-11.1720.938.76
Free Cash Flow
-26.55-33.54-28.32-18.96-10.67-4.07
Free Cash Flow Per Share
-12.45-20.24-23.80-19.43-14.43-26.56
Levered Free Cash Flow
-28.45-34-31.98-19.33-9.22-3
Unlevered Free Cash Flow
-28.9-35.36-32.24-19.28-10.81-4.76
Updated Aug 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q